Paradoxically, investigators also reported that treatment with 15‐deoxy‐Δ12,14‐PGJ2 decreases TNF‐α production in cardiomyocytes and reduces myocardial damage of ischemia/reperfusion (Zingarelli et al, 2007; Liu et al, 2009). The gene discussed is TNF; the disease is ischemia.